Skip to main content

Discovery of Hepatitis Viruses and Two Nobel Prizes: A Tale of Keen Observations, Serendipity, Collaborative Research, Astute Interpretations and Game-Changing Innovations

  • Chapter
  • First Online:
Biomedical Translational Research
  • 397 Accesses

Abstract

Chronic viral hepatitis, caused by hepatitis B and hepatitis C viruses, is one of the most common causes of end-stage liver disease and liver cancer in the world, and accounts for almost 4000 deaths per day. Fundamental research in chronic viral hepatitis has led to dramatic changes in its diagnosis, prevention and management. Indeed, the scientists credited with the discovery of hepatitis B (Baruch Blumberg) and hepatitis C (Harvey J. Alter, Michael Houghton and Charles M. Rice) were honoured with the Nobel Prize in 1976 and 2020, respectively. The story of the unravelling of the mysteries behind “serum hepatitis” and the establishment of its viral aetiology is an incredible testament to the remarkable accomplishments of modern biomedical research. In this chapter, we embark on a journey into the discovery of hepatitis B and C viruses, discuss the work of the Nobel laureates and throw light on the work of the unsung heroes without whose contributions, the discoveries may never have seen the light of day.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 169.00
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 219.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 219.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

References

  • Almeida JD, Rubenstein D, Stott EJ (1971) New antigen-antibody system in Australia-antigen-positive hepatitis. Lancet 2:1225–1226

    Article  CAS  Google Scholar 

  • Alter HJ (1981) Hepatitis B: a tribute to nondirected medical research. Semin Liver Dis 1:1–6

    Article  CAS  Google Scholar 

  • Alter HJ, Holland PV, Purcell RH, Lander JJ, Feinstone SM, Morrow AG et al (1972) Posttransfusion hepatitis after exclusion of commercial and hepatitis-B antigen-positive donors. Ann Intern Med 77:691–699

    Article  CAS  Google Scholar 

  • Alter HJ, Purcell RH, Holland PV, Popper H (1978) Transmissible agent in non-A, non-B hepatitis. Lancet 1:459–463

    Article  CAS  Google Scholar 

  • Bar-Gal GK, Kim MJ, Klein A, Shin DH, Oh CS, Kim JW et al (2012) Tracing hepatitis B virus to the 16th century in a Korean mummy. Hepatology 56:1671–1680

    Article  Google Scholar 

  • Baumert TF, Berg T, Lim JK, Nelson DR (2019) Status of direct-acting antiviral therapy for hepatitis C virus infection and remaining challenges. Gastroenterology 156:431–445

    Article  CAS  Google Scholar 

  • Blumberg BS (2002) Hepatitis B: the hunt for a killer virus. Princeton University Press, Princeton and Oxford, pp 72–146

    Book  Google Scholar 

  • Blumberg BS, Alter HJ, Visnich S (1965) A “new” antigen in leukemia sera. JAMA 191:541–546

    Article  CAS  Google Scholar 

  • Choo QL, Kuo G, Weiner AJ, Overby LR, Bradley DW, Houghton M (1989) Isolation of a cDNA clone derived from a blood-borne non-A, non-B viral hepatitis genome. Science 244:359–362

    Article  CAS  Google Scholar 

  • Cooke GS, Andrieux-Meyer I, Applegate TL, Atun R, Burry JR, Cheinquer H et al (2019) Accelerating the elimination of viral hepatitis: a Lancet Gastroenterology & Hepatology Commission. Lancet Gastroenterol Hepatol 4:135–184

    Article  Google Scholar 

  • Dane DS, Cameron CH, Briggs M (1970) Virus-like particles in serum of patients with Australia-antigen-associated hepatitis. Lancet 1:695–698

    Article  CAS  Google Scholar 

  • Dooley DP (2005) History of U.S. military contributions to the study of viral hepatitis. Mil Med 170:71–76

    Article  Google Scholar 

  • Feinstone SM, Kapikian AZ, Purcell RH, Alter HJ, Holland PV (1975) Transfusion associated hepatitis not due to viral hepatitis type A or B. N Engl J Med 292:767–770

    Article  CAS  Google Scholar 

  • Gocke DJ, Greenberg HB, Kavey NB (1970) Correlation of Australia antigen with post-transfusion hepatitis. JAMA 212:877–879

    Article  CAS  Google Scholar 

  • Goel A, Seguy N, Aggarwal R (2019) Burden of hepatitis C virus infection in India: a systematic review and meta-analysis. J Gastroenterol Hepatol (Australia) 34:321–329. https://doi.org/10.1111/jgh.14466

    Article  CAS  Google Scholar 

  • Goldby S (1971) Experiments at the Willowbrook State School. Lancet 1:749

    Article  CAS  Google Scholar 

  • Gruber W, Virchow R (1865) Ueber das Vorkommen und den Nachweis des hepatogenen, insbesondere des katarrhalischen Icterus. Arch Patholog Anat Und Physiol Und Für Klin Med 32:117–125

    Google Scholar 

  • Khuroo MS, Sofi AA (2020) The discovery of hepatitis viruses: agents and disease. J Clin Exp Hepatol 10:391–401. https://doi.org/10.1016/j.jceh.2020.04.006

    Article  PubMed  PubMed Central  Google Scholar 

  • Kolykhalov AA, Feinstone SM, Rice CM (1996) Identification of a highly conserved sequence element at the 3′ terminus of hepatitis C virus genome RNA. J Virol 70:3363–3371

    Article  CAS  Google Scholar 

  • Kolykhalov AA, Agapov EV, Blight KJ, Mihalik K, Feinstone SM, Rice CM (1997) Transmission of hepatitis C by intrahepatic inoculation with transcribed RNA. Science 277:570–574

    Article  CAS  Google Scholar 

  • Krugman S (1986) The Willowbrook hepatitis studies revisited: ethical aspects. Rev Infect Dis 8:157–162

    Article  CAS  Google Scholar 

  • Kuo G, Choo QL, Alter HJ, Gitnick GL, Redeker AG, Purcell RH et al (1989) An assay for circulating antibodies to a major etiologic virus of human non-A, non-B hepatitis. Science 244:362–364

    Article  CAS  Google Scholar 

  • Lohmann V, Korner F, Koch J, Herian U, Theilmann L, Bartenschlager R (1999) Replication of subgenomic hepatitis C virus RNAs in a hepatoma cell line. Science 285:110–113

    Article  CAS  Google Scholar 

  • Lok AS, Zoulim F, Dusheiko G, Ghany MG (2017) Hepatitis B cure: from discovery to regulatory approval. J Hepatol 67(4):847–861

    Article  Google Scholar 

  • London WT, Sutnick AI, Blumberg B (1969) Australia antigen and acute viral hepatitis. Ann Intern Med 70:55–59

    Article  CAS  Google Scholar 

  • Lürman A (1885) Eine Icterus Epidemic. Berlin Klin Wochenschr 22:207

    Google Scholar 

  • MacCallum FO (1943) Jaundice in syphilitics. Br J Vener Dis 19:63

    Google Scholar 

  • MacCallum FO (1947) Homologous serum jaundice. Lancet 2:691–692

    Google Scholar 

  • Murchison C, ByIhird LB, Fayrer J (1886) Clinical lectures on diseases of the liver, jaundice, and abdominal dropsy. Biomed J Digit Project 31

    Google Scholar 

  • Prince AM (1968) An antigen detected in the blood during the incubation period of serum hepatitis. Proc Natl Acad Sci U S A 60:814–821

    Article  CAS  Google Scholar 

  • Schmidt PJ (1999) Blood: an epic history of medicine and commerce. Transfusion 39:793–793. https://doi.org/10.1046/j.1537-2995.1999.39070793.x

    Article  Google Scholar 

  • Sood A, Suryaprasad A, Trickey A, Kanchi S, Midha V, Foster MA et al (2018) The burden of hepatitis C virus infection in Punjab, India: a population-based serosurvey. PLoS One 13:1–18. https://doi.org/10.1371/journal.pone.0200461

    Article  CAS  Google Scholar 

  • Stokes JH, Ruedemann R Jr, Lemon WS (1920) Epidemic infectious jaundice and its relation to the therapy of syphilis. Arch Int Med 26:521–543

    Article  Google Scholar 

  • Szmuness W, Stevens CE, Zang EA, Harley EJ, Kellner A (1981) A controlled clinical trial of the efficacy of the hepatitis B vaccine (Heptavax B): a final report. Hepatology 1(5):377–384

    Article  CAS  Google Scholar 

  • Tabor E, Gerety RJ, Drucker JA et al (1978) Transmission of non-A, non-B hepatitis from man to chimpanzee. Lancet 1:463–466

    Article  CAS  Google Scholar 

  • Tanaka T, Kato N, Cho MJ, Sugiyama K, Shimotohno K (1996) Structure of the 3′ terminus of the hepatitis C virus genome. J Virol 70:3307–3312

    Article  CAS  Google Scholar 

  • Tandon BN, Acharya SK, Tandon A (1996) Epidemiology of hepatitis B virus infection in India. Gut 38(Suppl 2):S56–S59

    Article  Google Scholar 

  • Trepo C (2014) A brief history of hepatitis milestones. Liver Int 34:29–37. https://doi.org/10.1111/liv.12409

    Article  CAS  PubMed  Google Scholar 

  • Walsh JH, Yalow RS, Berson SA (1970) Radioimmunoassay of Australia antigen. Vox Sang 19(3):217–224

    Article  CAS  Google Scholar 

  • WHO (2017) Global hepatitis report. World Health Organization, Geneva. http://apps.who.int/iris/bitstream/10665/255016/1/9789241565455-eng.pdf

    Google Scholar 

  • Wong DT, Martin CM, Boyer JL, Jain D (2015) Historical path of discovery of viral hepatitis. HMSR 3:18–36

    Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Editor information

Editors and Affiliations

Ethics declarations

All authors have no financial disclosures and declare no conflict of interest.

Rights and permissions

Reprints and permissions

Copyright information

© 2022 The Author(s), under exclusive license to Springer Nature Singapore Pte Ltd.

About this chapter

Check for updates. Verify currency and authenticity via CrossMark

Cite this chapter

De, A., Chawla, Y.K. (2022). Discovery of Hepatitis Viruses and Two Nobel Prizes: A Tale of Keen Observations, Serendipity, Collaborative Research, Astute Interpretations and Game-Changing Innovations. In: Sobti, R., Ganju, A.K. (eds) Biomedical Translational Research. Springer, Singapore. https://doi.org/10.1007/978-981-16-8845-4_9

Download citation

Publish with us

Policies and ethics